Lakefront Biotherapeutics NV current report, Q3 FY2018

Business Context and Reporting Period

This Form 6-K filing is submitted by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in the metadata request) for the month of September 2018, specifically dated September 11, 2018. The registrant is a foreign private issuer incorporated in Belgium, with its principal executive office in Mechelen. The filing serves to incorporate by reference a press release (Exhibit 99.1) issued on the same date.

Financial Metrics

The filing text provided does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing is a procedural submission to distribute a press release rather than a financial report.

Material Changes

No material financial changes versus prior periods are detailed in the text of this Form 6-K. The document references a press release (Exhibit 99.1) which likely contains the material event, but the content of that press release is not included in the provided input text.

Guidance, Outlook, and Risks

The filing does not provide management commentary, financial guidance, or specific risk factors. It notes that the information in the attached press release is incorporated by reference into various Registration Statements (Forms F-3 and S-8), excluding specific quotes from Dr. John McHutchison and Dr. Walid Abi-Saab.

Key Facts for Investor Verification

  • Company Identity: Verify that the filing pertains to Galapagos NV, not Lakefront Biotherapeutics NV.
  • Missing Content: The actual content of the press release (Exhibit 99.1) referenced in this filing is not present in the provided text; investors must locate the full press release to understand the material event.
  • Registration Statements: Note that this filing updates multiple active Registration Statements (File Nos. 333-211765, 333-204567, 333-208697, 333-211834, 333-215783, 333-218160, and 333-225263).
  • Reporting Period: The filing covers the month of September 2018, with the specific event date of September 11, 2018.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.